Location New York, New York, United States Regions Greater New York Area, East Coast, Northeastern US Gender Female
LinkedIn View on LinkedIn
Ingrid Bell has held leadership positions in healthcare digital marketing, regulatory, and policy for the last 14 years. In addition to her current role as co-founder and COO of Bonbouton, she serves on the board of directors for the Rogosin Institute, an affiliate of New York-Presbyterian and Weill Cornell Medicine, focusing on the treatment and
preventive care of kidney and other chronic disease patients. Prior to Bonbouton, she led execution of marketing campaigns for WebMD and has helped develop digital innovations for brands at Genentech. Previously, Ingrid consulted for pharmaceutical and biotech companies on their strategy to obtain regulatory approval in the US and EU and worked as a lobbyist on Capitol Hill focused on health policy for industry-leading clients. She received a bachelor’s degree in Biology at the University of Virginia.
